Floatz logo

Mlf 541

Digestive System Cancer

B. Braun Melsungen AGPhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

73 Active assets in the Digestive System Cancer cohort.

Asset / SponsorPhaseRating
FLUOROURACILUM
Alliance for Clinical Trials in Oncology
Phase 2BB
DEXAMETHASONE
Cedars-Sinai Medical Center
Phase 4BB
Irinotecan
Amgen
Phase 2BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
Brian Anderson, MD
Phase 4BB
Epinephrine
Cedars-Sinai Medical Center
Phase 4BB

View all 50 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →